FDA authorized Tregzi for adults with acute leukemia, MDS, and other hematologic malignancies receiving closely matched donor ...
MedPage Today on MSN
Orca-T approved to prevent GVHD after stem cell transplant for blood cancers
Regulatory T cell-based immunotherapy approved for use in matched-donor HSCTs ...
Morning Overview on MSN
The FDA approved a first-of-its-kind cell therapy for blood-cancer transplant patients
Adults with blood cancers who receive stem cell transplants from matched donors now have a new defense against one of the ...
Tregzi uses stem cells and immune cells collected from blood of a closely matched donor to help the body fight cancer while ...
On September 27, 2024, in USA v. California Stem Cell Treatment Center, Inc., the US Court of Appeals for the Ninth Circuit issued a decision agreeing with the US Food and Drug Administration (FDA) ...
Researchers advance scalable stem-cell bioprocessing with AI-enabled manufacturing for regenerative medicine therapies.
All cell types found in the body are derived from stem cells. However, genetic mutations can impact the ability of stem cells to develop into fully functional cells. Also, as the body ages, the number ...
On September 27, 2024, the U.S. Court of Appeals for the Ninth Circuit reversed the district court’s decision in U.S. v. California Stem Cell Treatment Center, Inc. (“California Stem Cell”), holding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results